The Chinese government has announced that it has conditionally approved the import of a drench to prevent the aggravation of the new coronavirus developed by American pharmaceutical giant Pfizer.
According to Chinese media, it is the first time that the Chinese government has approved a new coronavirus drug.
China's National Pharmaceutical Products Administration announced on the 12th that it has approved the import of Pfizer's new coronavirus, Paxrovid, which is used to prevent the aggravation of the disease, on the 11th.
As a condition of approval, the seller is required to submit the results of research related to this drug to the authorities.
In the United States, the FDA = Food and Drug Administration issued an emergency use authorization in December last year, and in Japan, the drug was approved for use under the brand name "Pakirovid Pack" on the 10th.
According to Chinese media, it is the first time that the Chinese government has approved a new coronavirus drug.
China continues its "Zero Corona" policy, which does not allow even the slightest spread of infection, but sporadic infections are still found in various parts of the country.
According to health officials, more than 1.2 billion people in China have been vaccinated with the vaccine, but with the infection of the highly infectious Omicron strain, the approval of this drug gives them treatment options. It seems that there is an aim to expand it.